MLchartDataset catalogue

DFS

Term · Oncology and biomedicine · MLC-T-ONC-002399

In cancer, the length of time after primary treatment for a cancer ends that the patient survives without any signs or symptoms of that cancer. In a clinical trial, measuring the DFS is one way to see how well a new treatment works. Also called disease-free survival, relapse-free survival, and RFS.

Table 1. Record
IdentifierMLC-T-ONC-002399
FieldOncology and biomedicine
Expansionsdisease-free survival; relapse-free survival
SynonymsRFS
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002399",
  "term": "DFS",
  "field": "Oncology and biomedicine",
  "definition": "In cancer, the length of time after primary treatment for a cancer ends that the patient survives without any signs or symptoms of that cancer. In a clinical trial, measuring the DFS is one way to see how well a new treatment works. Also called disease-free survival, relapse-free survival, and RFS.",
  "expansions": [
    "disease-free survival",
    "relapse-free survival"
  ],
  "synonyms": [
    "RFS"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/dfs/"
}

Record 5,908 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.